Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tango Therapeutics, Inc.(TNGX) | 9,771,485 | 10,876,219 | +1,104,734 | $82.08M | $96.36M | 21.09% | +$14.28M |
| Revolution Medicines, Inc.(RVMD) | 400,000 | 400,000 | 0 | $18.68M | $31.86M | 6.97% | +$13.18M |
| Kodiak Sciences Inc.(KOD) | 750,000 | 1,136,000 | +386,000 | $12.28M | $31.76M | 6.95% | +$19.49M |
| Kymera Therapeutics, Inc.(KYMR) | 319,100 | 329,100 | +10,000 | $18.06M | $25.61M | 5.60% | +$7.55M |
| Celcuity Inc.(CELC) | 90,000 | 225,000 | +135,000 | $4.45M | $22.44M | 4.91% | +$18.00M |
| ABIVAX Société AnonymeADS(ABVX) | 120,000 | 125,000 | +5,000 | $10.19M | $16.86M | 3.69% | +$6.67M |
| PTC Therapeutics, Inc.(PTCT) | 200,000 | 200,000 | 0 | $12.27M | $15.19M | 3.33% | +$2.92M |
| Terns Pharmaceuticals Inc | 0 | 375,000 | +375,000 | $0 | $15.15M | 3.32% | +$15.15M |
| Protagonist Therapeutics Inc | 110,000 | 170,000 | +60,000 | $7.31M | $14.85M | 3.25% | +$7.54M |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 46,457 | +46,457 | $0 | $13.69M | 3.00% | +$13.69M |
| UroGen Pharma Ltd.(URGN) | 575,000 | 500,000 | -75,000 | $11.47M | $11.71M | 2.56% | +$238.8K |
| Cidara Therapeutics Inc | 48,000 | 53,000 | +5,000 | $4.60M | $11.71M | 2.56% | +$7.11M |
| Palisade Bio, Inc.(PALI) | 0 | 4,799,875 | +4,799,875 | $0 | $11.28M | 2.47% | +$11.28M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 900,000 | 800,000 | -100,000 | $12.23M | $9.66M | 2.12% | -$2.57M |
| Surrozen, Inc.(SRZN) | 0 | 416,150 | +416,150 | $0 | $9.40M | 2.06% | +$9.40M |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 325,000 | +325,000 | $0 | $9.38M | 2.05% | +$9.38M |
| Mind Medicine Mindmed Inc | 163,500 | 598,500 | +435,000 | $1.93M | $8.01M | 1.75% | +$6.09M |
| Cogent Biosciences, Inc.(COGT) | 0 | 225,000 | +225,000 | $0 | $7.99M | 1.75% | +$7.99M |
| Replimune Group, Inc.(REPL) | 1,050,000 | 750,000 | -300,000 | $4.40M | $7.29M | 1.60% | +$2.89M |
| uniQure N.V.SHS(QURE) | 800,000 | 290,000 | -510,000 | $46.70M | $6.94M | 1.52% | -$39.76M |
| Cytokinetics, Incorporated(CYTK) | 200,000 | 100,000 | -100,000 | $10.99M | $6.35M | 1.39% | -$4.64M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 715,000 | +715,000 | $0 | $5.85M | 1.28% | +$5.85M |
| Precigen, Inc.(PGEN) | 850,000 | 1,375,000 | +525,000 | $2.80M | $5.75M | 1.26% | +$2.95M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 494,000 | +494,000 | $0 | $5.65M | 1.24% | +$5.65M |
| Crescent Biopharma, Inc.(CBIO) | 453,686 | 453,686 | 0 | $5.39M | $5.38M | 1.18% | -$13.6K |
| Apogee Therapeutics Inc | 50,000 | 70,000 | +20,000 | $1.99M | $5.28M | 1.16% | +$3.30M |
| Structure Therapeutics IncADS | 0 | 75,000 | +75,000 | $0 | $5.22M | 1.14% | +$5.22M |
| Avalo Therapeutics, Inc.(AVTX) | 125,000 | 275,000 | +150,000 | $1.59M | $4.99M | 1.09% | +$3.41M |
| Inovio Pharmaceuticals, Inc.(INO) | 2,300,000 | 2,420,122 | +120,122 | $5.38M | $4.21M | 0.92% | -$1.17M |
| Upstream Bio, Inc.(UPB) | 0 | 150,000 | +150,000 | $0 | $4.07M | 0.89% | +$4.07M |
| Vir Biotechnology, Inc.(VIR) | 0 | 625,000 | +625,000 | $0 | $3.77M | 0.82% | +$3.77M |
| Invivyd, Inc.(IVVD) | 0 | 1,500,000 | +1,500,000 | $0 | $3.71M | 0.81% | +$3.71M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 250,000 | 275,000 | +25,000 | $1.79M | $3.62M | 0.79% | +$1.83M |
| Sarepta Therapeutics, Inc.(SRPT) | 250,000 | 150,000 | -100,000 | $4.82M | $3.23M | 0.71% | -$1.59M |
| PepGen Inc.(PEPG) | 250,000 | 373,892 | +123,892 | $1.16M | $2.43M | 0.53% | +$1.28M |
| Nurix Therapeutics, Inc.(NRIX) | 175,000 | 100,000 | -75,000 | $1.62M | $1.90M | 0.42% | +$280.0K |
| Karyopharm Therapeutics Inc.(KPTI) | 0 | 252,536 | +252,536 | $0 | $1.86M | 0.41% | +$1.86M |
| Solid Biosciences Inc | 600,000 | 300,000 | -300,000 | $3.70M | $1.69M | 0.37% | -$2.01M |
| LB Pharmaceuticals Inc(LBRX) | 70,000 | 70,000 | 0 | $1.11M | $1.56M | 0.34% | +$452.9K |
| Milestone Pharmaceuticals Inc.(MIST) | 666,666 | 666,666 | 0 | $1.33M | $1.35M | 0.29% | +$13.3K |
| Clene Inc.(CLNN) | 0 | 199,737 | +199,737 | $0 | $1.17M | 0.26% | +$1.17M |
| Kalvista Pharmaceuticals Inc | 20,400 | 20,400 | 0 | $248.5K | $329.5K | 0.07% | +$81.0K |
| Zura Bio LimitedCL A(ZURA) | 0 | 50,000 | +50,000 | $0 | $262.0K | 0.06% | +$262.0K |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 266,666 | 266,666 | 0 | $53.9K | $88.0K | 0.02% | +$34.1K |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 66,666 | 66,666 | 0 | $1.0K | $1.3K | 0.00% | +$333 |
| Merus N V | 120,000 | 0 | -120,000 | $11.30M | $0 | — | -$11.30M |
| Nektar Therapeutics(NKTR) | 125,000 | 0 | -125,000 | $7.11M | $0 | — | -$7.11M |
| Denali Therapeutics Inc.(DNLI) | 250,000 | 0 | -250,000 | $3.63M | $0 | — | -$3.63M |
| Instil Bio, Inc.(TIL) | 60,700 | 0 | -60,700 | $1.08M | $0 | — | -$1.08M |